RESULTS:
A total of 532 patients met inclusion criteria. In the 0-1-month group 81 patients had an average CI of 0.82 (SD ±0.042). There were 99 patients in the 4-6-month group, with a mean CI of 0.86 (SD ±0.053). Current helmeting norms in this 0-6-month age range are >0.837 for boys and >0.827 in girls.
3 In this sample of children under 6 months, n= 51(57.3%) of the boys and n= 53(45.32%) of girls meet criteria for a helmet. (See Graphic) At 9-12 months, a sample of 81 patients had a CI of 0.84 (SD 0.061). This value was stable at 2-3 years, with mean CI of 0.83 and SD 0.077 (n=113), and at 12-14 years, CI 0.82, SD 0.062 (n=148).
CONCLUSIONS:
The mean cephalic index of healthy children in this sample aged 0-1 month and 4-6 months was 0.83 and 0.86, respectively. These values are higher than previously established mean CI values for children under 6 months of .737(males) and .733(females) by Farkus et al demonstrating a global change in CI after the introduction of the Back to Sleep campaign.
7 Our study also shows that up to 57% of children may inappropriately meet criteria for a helmet based on the prior norms. By updating data to reflect current norms, many children may be spared an unnecessary helmet orthosis. PURPOSE: Autologous fat grafting is an important adjunct to soft-tissue reconstruction. However, it is associated with multiple complications including poor volume retention. There currently exist no tissue scaffold materials that aid in human fat graft retention. The purpose of this study is to demonstrate that our novel nanofiber-hydrogel composite serves as a tissue scaffold that improves fat graft retention and promotes enhanced graft vascularization.
METHODS:
The following groups were studied: 100% lipoaspirate, 50% lipoaspirate/50% composite, 50% lipoaspirate/50% hydrogel, 75% lipoaspirate/25% composite, and 100% composite (n=15 per group). 500uL of material was subcutaneously injected into both flanks of Foxn1nu NU/J male mice. Mice were imaged using MRI at post-operative day (POD) 2, 28, 56, and 84 to assess graft volume. Grafts were explanted on days 7, 28, and 84. Immunohistochemistry (IHC) was performed on explanted grafts to evaluate vascularization. Microfilament perfusion was performed on mice and imaged via computed-tomographic scans to further assess microvasculature of grafts.
RESULTS:
Composite-containing groups demonstrated the highest volume retention on POD84. On IHC, groups containing the nanofiber-hydrogel composite demonstrated superior rates of angiogenesis and blood vessel ingrowth into the graft as compared to other groups. Results of microfilament perfusion show superior vascularity of composite-containing grafts.
CONCLUSION:
Both groups containing lipoaspirate/ composite exhibited superior volume retention at POD 84 as well as higher degrees of angiogenesis compared to solely lipoaspirate or lipoaspirate/hydrogel combination. This has important clinical implications, as improved fat graft retention would save patients the morbidity of undergoing multiple surgical procedures.
